跳转到主内容

非常抱歉,我们不完全支持您的浏览器。如果您可以选择,请升级到较新版本或使用 Mozilla Firefox、Microsoft Edge、Google Chrome 或 Safari 14 或更高版本。如果您无法进行此操作且需要支持,请将您的反馈发送给我们。

全新设计的官网为您带来全新体验,期待您的反馈 在新的选项卡/窗口中打开

Elsevier
通过我们出版
Helping to Mitigate Risk in GenAI Tools for CDS
Whitepaper

Helping to Mitigate Risk in GenAI Tools for CDS

Elsevier uses a robust evaluation framework to assess ClinicalKey AI, its generative AI-powered clinical decision support tool, for efficacy and bias. Generative AI technologies hold immense potential to tackle challenges from boosting operational efficiencies to enhancing clinical decision support. However, their true value can only be realized when they are used safely, responsibly, and ethically. Read the white paper to gain insights into:

  • The importance of rigorous evaluation frameworks for generative AI in healthcare

  • Strategies to mitigate risks, including AI “hallucinations” and potential biases

  • The methodology used by Elsevier to evaluate the performance of ClinicalKey AI

Helping to Mitigate Risk in GenAI Tools for CDS

Helping to Mitigate Risk in GenAI Tools for CDS

Download here  在新的选项卡/窗口中打开